We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

287 hedge funds and large institutions have $5.38B invested in United Therapeutics in 2013 Q2 according to their latest regulatory filings, with 287 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $13.1M

Holders
287
Holders Change
+287
Holders Change %
–
% of All Funds
9.37%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
287
Increased
–
Reduced
–
Closed
–
Calls
$13.5M
Puts
$13.1M
Net Calls
+$400K
Net Calls Change
+$400K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
1
BNP Paribas Financial Markets
France
$1.82B +$815M +12,655,783 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$318M +$312M +4,837,098 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$174M +$170M +2,639,188 New
LSV Asset Management
4
LSV Asset Management
Illinois
$172M +$169M +2,617,361 New
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$132M +$129M +2,004,519 New
AL
6
AJO LP
Pennsylvania
$132M +$129M +2,003,170 New
EAM
7
Eagle Asset Management
Florida
$116M +$114M +1,769,176 New
BFA
8
BlackRock Fund Advisors
California
$112M +$110M +1,703,388 New
State Street
9
State Street
Massachusetts
$105M +$103M +1,591,438 New
Bank of Montreal
10
Bank of Montreal
Ontario, Canada
$98.2M +$96.1M +1,492,141 New
BIT
11
BlackRock Institutional Trust
California
$96M +$94M +1,459,160 New
BA
12
BlackRock Advisors
Delaware
$93.3M +$91.3M +1,417,108 New
Wellington Management Group
13
Wellington Management Group
Massachusetts
$88M +$86.1M +1,336,812 New
Invesco
14
Invesco
Georgia
$74M +$72.4M +1,123,577 New
HCM
15
Herndon Capital Management
Georgia
$67.5M +$66M +1,024,905 New
PAI
16
Palo Alto Investors
California
$59.3M +$58M +900,778 New
Bank of New York Mellon
17
Bank of New York Mellon
New York
$58.7M +$57.4M +891,783 New
Schroder Investment Management Group
18
Schroder Investment Management Group
United Kingdom
$53.3M +$52.2M +809,921 New
FCM
19
Frontier Capital Management
Massachusetts
$52.3M +$51.2M +794,257 New
Arrowstreet Capital
20
Arrowstreet Capital
Massachusetts
$44.2M +$43.3M +672,066 New
SCP
21
Seizert Capital Partners
Michigan
$43.3M +$42.4M +657,662 New
Wells Fargo
22
Wells Fargo
California
$39.7M +$38.9M +603,722 New
Renaissance Technologies
23
Renaissance Technologies
New York
$38.9M +$38M +590,378 New
TSW
24
Thompson Siegel & Walmsley
Virginia
$38M +$37.2M +577,916 New
First Trust Advisors
25
First Trust Advisors
Illinois
$37.3M +$36.5M +566,337 New
1
2 3 4 5

UTHR Hedge Fund Activity: Q2 2013 in Review

287 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2013, worth a combined $5.38B.

Buyers outnumbered sellers: 287 funds opened new UTHR positions and 0 closed out — a net gain of 287 holders — while 0 added to existing stakes and 0 trimmed.

  • 287 institutional investors held United Therapeutics (UTHR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.38B of United Therapeutics stock for Q2 2013.
  • 287 funds opened new United Therapeutics positions in Q2 2013 and 0 closed out, a net change of +287 holders.

Based on aggregated 13F filings for Q2 2013.